EUVIMEDScopri EUVIMED
Editorial

Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply

Runqi Wang iD, Dongxing Cao, Zhe Cui iD

Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (11) · 1567-1568

DOI: 10.1111/apt.70672 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-04-15. Written by Runqi Wang and 2 co-authors. Institution: Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. 8 references.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Abstract non disponibile.

Authors and institutions

  • Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Department of General Surgery, Baoshan Branch, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

ORCID profiles: Runqi Wang, Zhe Cui

Cite

APA

Wang, R., Cao, D., & Cui, Z. (2026). Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics, 63(11), 1567-1568. https://doi.org/10.1111/apt.70672

Vancouver

Wang R, Cao D, Cui Z. Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;63(11):1567-1568. doi:10.1111/apt.70672

BibTeX
@article{Wang2026,
  author = {Wang, Runqi and Cao, Dongxing and Cui, Zhe},
  title = {Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {11},
  pages = {1567--1568},
  doi = {10.1111/apt.70672}
}
Start for free →